UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported) October 8, 2008
MetLife, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
| |
|
|
| 1-15787
|
|
13-4075851 |
| |
| (Commission File Number)
|
|
(IRS Employer Identification No.) |
| |
|
|
| 200 Park Avenue, New York, New York
|
|
10166-0188 |
| |
| (Address of Principal Executive Offices)
|
|
(Zip Code) |
212-578-2211
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
| o |
|
Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
Item 8.01 Other Events
On October 8, 2008, MetLife, Inc., a Delaware corporation (“MetLife”),
entered into (i) an underwriting agreement (attached hereto as Exhibit 1.1 and
incorporated herein by reference), and (ii) a pricing agreement (attached
hereto as Exhibit 1.2 and incorporated herein by reference) (the “Pricing
Agreement”) relating to the sale of 75,000,000 shares of MetLife’s common stock, par value
$0.01 per share (the “Common Stock”), each among MetLife and Credit Suisse
Securities (USA) LLC, as representative of the several underwriters named in
Schedule I to the Pricing Agreement (the
“Underwriters”), at an initial public offering price of $26.50 per share.
To the extent that the Underwriters sell more than 75,000,000 shares of Common
Stock, the Underwriters have the option (for 30 days from the date of the underwriting agreement) to purchase up to an additional
11,250,000 shares of Common Stock from MetLife.
The Common Stock is being offered and sold pursuant to the shelf
registration statement on Form S-3 (File No. 333-147180) filed with the U.S.
Securities and Exchange Commission (the “Commission”) on November 6, 2007, and
a prospectus supplement dated October 8, 2008 (the “Prospectus Supplement”).
The terms of the Common Stock are set forth in the Prospectus Supplement
(filed on October 10, 2008 with the Commission pursuant to
Rule 424(b)(2) under the Securities Act).
Item 9.01. Financial Statements and Exhibits.
| |
(a) |
|
Not applicable. |
| |
| |
(b) |
|
Not applicable. |
| |
| |
(c) |
|
Not applicable. |
| |
| |
(d) |
|
Exhibits |
| |
1.1 |
|
Underwriting Agreement dated October 8, 2008 among
MetLife and the Underwriters. |
| |
|
|
|
| |
1.2 |
|
Pricing Agreement dated October 8, 2008 among
MetLife and the Underwriters. |